Cargando…

Autoimmune and Chronic Inflammatory Disease Patients with COVID‐19

OBJECTIVE: There are limited data on the impact of coronavirus disease 2019 (COVID‐19) on hospitalized patients with autoimmune and chronic inflammatory disease (AICID) compared with patients who do not have AICID. We sought to evaluate whether patients with AICID who have confirmed COVID‐19 present...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ungaro, Ryan C., Agrawal, Manasi, Park, Sarah, Hirten, Robert, Colombel, Jean‐Frederic, Twyman, Kathryn, Gulko, Percio S., Klang, Eyal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882518/ https://www.ncbi.nlm.nih.gov/pubmed/33527691 http://dx.doi.org/10.1002/acr2.11221

Ejemplares similares

Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry
por: Spiera, Emily, et al.
Publicado: (2022)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry
por: Ungaro, Ryan C., et al.
Publicado: (2022)

Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Parekh, Rajen, et al.
Publicado: (2021)

Fr498 NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH COVID-19: DATA FROM AN INTERNATIONAL REGISTRY
por: Ungaro, Ryan C., et al.
Publicado: (2021)

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE
por: Spiera, Emily, et al.
Publicado: (2022)

Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease
por: Parekh, Rajen, et al.
Publicado: (2021)

COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case–control study
por: Hong, Simon J., et al.
Publicado: (2022)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2021)

The arthritis severity locus Cia5a regulates the expression of inflammatory mediators including Syk pathway genes and proteases in pristane-induced arthritis
por: Brenner, Max, et al.
Publicado: (2012)

Fr509 COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC MINORITY INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASES IN THE UNITED STATES
por: Agrawal, Manasi, et al.
Publicado: (2021)

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY
por: Spiera, Emily, et al.
Publicado: (2022)

Su1482: SCOUT IBD: SURVEILLANCE OF COVID-19 IMPACT ON LONG-TERM OUTCOMES IN IBD
por: Hong, Simon J., et al.
Publicado: (2022)

Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
por: Hong, Simon J., et al.
Publicado: (2022)

Changing epidemiology of immune-mediated inflammatory diseases in immigrants: a systematic review of population-based studies
por: Agrawal, Manasi, et al.
Publicado: (2019)

COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions
por: Ungaro, Ryan C., et al.
Publicado: (2021)

COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease
por: Spiera, Emily, et al.
Publicado: (2022)

JAK Inhibitors Safety in Ulcerative Colitis: Practical Implications
por: Agrawal, Manasi, et al.
Publicado: (2020)

Fr491 MULTIVARIABLE PREDICTION MODELS FOR HOSPITALIZATION, VENTILATION, AND DEATH FROM COVID-19 IN IBD PATIENTS
por: Sperger, John, et al.
Publicado: (2021)

Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD
por: Sperger, John, et al.
Publicado: (2021)

Development and validation of multivariable prediction models for adverse COVID-19 outcomes in IBD patients
por: Sperger, John, et al.
Publicado: (2021)

Combination therapy of a TRPV2 agonist with a TNF inhibitor achieves sustained suppression of disease severity and reduced joint damage
por: Laragione, Teresina, et al.
Publicado: (2022)

Impact of COVID-19 on Healthcare Resource Utilisation Among Patients with Inflammatory Bowel Disease in the USA
por: Ungaro, Ryan C, et al.
Publicado: (2022)

Vitamin C Deficiency in Inflammatory Bowel Disease: The Forgotten Micronutrient
por: Dunleavy, Katie A, et al.
Publicado: (2021)

Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
por: Wong, Serre-Yu, et al.
Publicado: (2021)

COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States
por: Agrawal, Manasi, et al.
Publicado: (2021)

What Should Gastroenterologists and Patients Know About COVID-19?
por: Ungaro, Ryan C., et al.
Publicado: (2020)

Sa502 THE FIRST AND SECOND WAVE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TEMPORAL TREND ANALYSIS
por: Kaplan, Gilaad, et al.
Publicado: (2021)

Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients
por: Ricciuto, Amanda, et al.
Publicado: (2021)

The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis
por: Kaplan, Gilaad G, et al.
Publicado: (2022)

Cia5d regulates a new fibroblast-like synoviocyte invasion-associated gene expression signature
por: Laragione, Teresina, et al.
Publicado: (2008)

Synovial expression of Th17-related and cancer-associated genes is regulated by the arthritis severity locus Cia10
por: Jenkins, Emma, et al.
Publicado: (2011)

Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

IBD in the COVID-19 era: the value of international collaboration
por: Brenner, Erica J, et al.
Publicado: (2020)

A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review
por: Ungaro, Ryan, et al.
Publicado: (2019)

Whole-Genome Sequences of DA and F344 Rats with Different Susceptibilities to Arthritis, Autoimmunity, Inflammation and Cancer
por: Guo, Xiaosen, et al.
Publicado: (2013)

Reply
por: Brenner, Erica J., et al.
Publicado: (2021)

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
por: Spencer, Elizabeth A, et al.
Publicado: (2021)

Magnesium increases numbers of Foxp3+ Treg cells and reduces arthritis severity and joint damage in an IL-10-dependent manner mediated by the intestinal microbiome
por: Laragione, Teresina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c3112hpaplvg6tt3p1dj31v2s8